Reza Halse

President chez RA Capital Management LP (Private Equity)

Profil

Reza Halse currently works at Summation Bio, Inc., as Director, CinRx Pharma LLC, as President from 2026, MRL Ventures Fund LLC, as President, Partners Research Ventures & Licensing, as Partner, Droia Ventures, as Partner, and RA Capital Management LP (Private Equity), as President from 2021.
Dr. Halse also formerly worked at TargAnox, Inc., as Chief Executive Officer from 2014 to 2015, Genome Canada, as Chairman from 2013 to 2016, Visterra, Inc., as Director, Novartis Pharmaceuticals, as Associate Director from 2004 to 2008, IOmet Pharma Ltd., as Director, Spero Therapeutics, Inc., as Director, Alector, Inc., as Director, Raze Therapeutics, Inc., as Director, BioMed Valley Discoveries, Inc., as Director from 2008 to 2011, Biocom, Inc., as Member-Governors Board, Partners HealthCare Corp., as Partner from 2012 to 2015, Xcellsyz Ltd., as Head-Cell Biology, Merck Research Ventures, as President from 2017 to 2021, and LAVA Therapeutics NV, as Member-Supervisory Board.
Dr. Halse received his undergraduate degree and doctorate degree from The University of Newcastle.

Postes actifs de Reza Halse

Sociétés	Poste	Début
Partners Research Ventures & Licensing	Corporate Officer/Principal	-
RA Capital Management LP (Private Equity)	President	01/03/2021
Summation Bio, Inc.	Directeur/Membre du Conseil	-
DROIA NV	Private Equity Investor	-
MRL Ventures Fund LLC	President	-
CinRx Pharma LLC	President	10/02/2026

Anciens postes connus de Reza Halse

Sociétés	Poste	Fin
Merck Research Ventures	President	31/03/2021
IOmet Pharma Ltd.	Directeur/Membre du Conseil	21/06/2018
Genome Canada	Président	30/06/2016
░░░░░░░░ ░░░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░